Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10976049 | 0.93 | GMNN (0.43) | — | |
| SCHEMBL10976003 | 0.92 | — | — | |
| Bromide SCHEMBL10972352 | 0.91 | — | — | |
| Bromide SCHEMBL10973334 | 0.91 | — | — | |
| SCHEMBL10972622 | 0.86 | GMNN (0.43) | — | |
| SCHEMBL10974214 | 0.85 | LMNA (0.44) | — | |
| SCHEMBL10549306 | 0.81 | GMNN (0.42) | — | |
| SCHEMBL9829675 | 0.81 | — | — | |
| SCHEMBL10975564 | 0.80 | — | — | |
| Iodide SCHEMBL10821902 | 0.77 | KDM4E (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0836852-A1 | Use of amlexanox for the manufacture of a medicament for treating aphtous ulcers | CHEMEX/BLOCK DRUG, JV (US) | 1998-04-22 | — | — | EP | disclosed |